Kingsview Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Buy |
102,638
+85,598
| +502% | +$433K | 0.01% | 756 |
|
|
2025
Q1 | $90.1K | Sell |
17,040
-680
| -4% | -$3.6K | ﹤0.01% | 1067 |
|
|
2024
Q4 | $120K | Sell |
17,720
-4,820
| -21% | -$32.6K | ﹤0.01% | 1075 |
|
|
2024
Q3 | $149K | Sell |
22,540
-671
| -3% | -$4.42K | ﹤0.01% | 1055 |
|
|
2024
Q2 | $174K | Sell |
23,211
-820
| -3% | -$6.15K | ﹤0.01% | 1001 |
|
|
2024
Q1 | $240K | Buy |
+24,031
| New | +$240K | 0.01% | 904 |
|